Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Canntab Therapeutics Limited (TSE:PILL)
CNQX:PILL
Canntab Therapeutics Limited (PILL) Stock Price & Analysis
9 Followers
PILL Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week Range<C$0.01 - C$0.02
Previous CloseC$0.01
Volume22.23K
Average Volume (3M)N/A
Market Cap
C$194.55K
Enterprise ValueC$2.07M
Total Cash (Recent Filing)C$16.81K
Total Debt (Recent Filing)C$1.90M
Price to Earnings (P/E)-0.1
Beta1.06
Next Earnings
Apr 30, 2024EPS EstimateN/A
Last Dividend Ex-Date
Mar 08, 2016Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding38,909,159
10 Day Avg. Volume9,253
30 Day Avg. VolumeN/A
Standard Deviation0.22
R-Squared0.07
Alpha-0.07
Financial Highlights & Ratios
Price to Book (P/B)-0.08
Price to Sales (P/S)8.78
Price to Cash Flow (P/CF)-1.30
P/FCF Ratio0.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Canntab Therapeutics Limited News
PremiumCompany Announcements
Canntab Therapeutics Plans Fundraising Amid Trade SanctionsPILL FAQ
What was Canntab Therapeutics Limited’s price range in the past 12 months?
Canntab Therapeutics Limited lowest stock price was <C$0.01 and its highest was C$0.02 in the past 12 months.
What is Canntab Therapeutics Limited’s market cap?
Currently, no data Available
When is Canntab Therapeutics Limited’s upcoming earnings report date?
Canntab Therapeutics Limited’s upcoming earnings report date is Apr 30, 2024 which is 3 days ago.
How were Canntab Therapeutics Limited’s earnings last quarter?
Currently, no data Available
Is Canntab Therapeutics Limited overvalued?
According to Wall Street analysts Canntab Therapeutics Limited’s price is currently Overvalued.
Does Canntab Therapeutics Limited pay dividends?
Canntab Therapeutics Limited pays a Notavailable dividend of C$0.01 which represents an annual dividend yield of N/A. See more information on Canntab Therapeutics Limited dividends here
What is Canntab Therapeutics Limited’s EPS estimate?
Canntab Therapeutics Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Canntab Therapeutics Limited have?
Canntab Therapeutics Limited has 38,909,160 shares outstanding.
What happened to Canntab Therapeutics Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Canntab Therapeutics Limited?
Currently, no hedge funds are holding shares in TSE:PILL
---
Canntab Therapeutics Limited Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Company Description
Canntab Therapeutics Limited
Canntab Therapeutics Ltd is a Canadian cannabis oral dosage formulation company based in Markham Ontario, engaged in the research and development of advanced pharmaceutical grade formulations of cannabinoids. It has developed in-house technology to deliver standardized medical cannabis extract from selective strains in a variety of extended/sustained release pharmaceutical dosages for therapeutic use.
---
---